What does DR. KAREL BUYSE ,HUISARTS do?

DR. KAREL BUYSE ,HUISARTS is a general practice in Beveren-Kruibeke-Zwijndrecht. Private Limited, started on 19 April 2021, 1 establishment.

What is the address of DR. KAREL BUYSE ,HUISARTS?

The registered office of DR. KAREL BUYSE ,HUISARTS is located at Donckerhoevestraat 7, 9150 Beveren-Kruibeke-Zwijndrecht.

Is DR. KAREL BUYSE ,HUISARTS still active?

Yes. According to the CBE (19 September 2026) DR. KAREL BUYSE ,HUISARTS is active, legal situation “Normale toestand”, started on 19 April 2021.

Is DR. KAREL BUYSE ,HUISARTS registered on Peppol?

Yes, DR. KAREL BUYSE ,HUISARTS is registered on the Peppol network with ID 0208:0766894569.

What is the enterprise number of DR. KAREL BUYSE ,HUISARTS?

The enterprise number of DR. KAREL BUYSE ,HUISARTS is BE0766894569.

When was DR. KAREL BUYSE ,HUISARTS founded?

DR. KAREL BUYSE ,HUISARTS was founded on 19 April 2021.

Who are the directors of DR. KAREL BUYSE ,HUISARTS?

According to the 2025 annual accounts, the directors of DR. KAREL BUYSE ,HUISARTS are: Karel Buyse.

Is DR. KAREL BUYSE ,HUISARTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 April 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. KAREL BUYSE ,HUISARTS make in 2025?

DR. KAREL BUYSE ,HUISARTS posted a profit after taxes of € 108,557 in financial year 2025.

What is the revenue of DR. KAREL BUYSE ,HUISARTS?

As a small company, DR. KAREL BUYSE ,HUISARTS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 145,778.

DR. KAREL BUYSE ,HUISARTS (Private Limited)

Dossier DR. KAREL BUYSE ,HUISARTS, printed on 19 September 2026 from databakkes.be/en/0766894569/dr-karel-buyse-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. KAREL BUYSE ,HUISARTS from Beveren-Kruibeke-Zwijndrecht, company number BE0766894569, closed financial year 2025 with a result of € 108,557 after tax. For that financial year DR. KAREL BUYSE ,HUISARTS recorded a gross margin of € 145,778 and equity of € 3,000. Compared with financial year 2024, the result moved from € 99,184 to € 108,557. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 8, 2026.

What it is worth Healthy

€ 3,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 108,557

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 41,799

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 108,557 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,070

▼ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 17,158

▼ 34% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 113,240 Gross margin 2022: € 113,240 First fiscal year in the series	€ 103,614 Gross margin 2023: € 103,614 ▼ 9% vs 2022 (€ 113,240) Unfavourable step	€ 132,788 Gross margin 2024: € 132,788 ▲ 28% vs 2023 (€ 103,614) Favourable step	€ 145,778 Gross margin 2025: € 145,778 ▲ 10% vs 2024 (€ 132,788) Favourable step	▲ 10%
Profit after taxes	€ 87,050 Profit after taxes 2022: € 87,050 First fiscal year in the series	€ 80,138 Profit after taxes 2023: € 80,138 ▼ 8% vs 2022 (€ 87,050) Unfavourable step	€ 99,184 Profit after taxes 2024: € 99,184 ▲ 24% vs 2023 (€ 80,138) Favourable step	€ 108,557 Profit after taxes 2025: € 108,557 ▲ 9% vs 2024 (€ 99,184) Favourable step	▲ 9%
Equity	€ 240,025 Equity 2022: € 240,025 First fiscal year in the series	€ 320,163 Equity 2023: € 320,163 ▲ 33% vs 2022 (€ 240,025) Favourable step	€ 3,000 Equity 2024: € 3,000 ▼ 99% vs 2023 (€ 320,163) Unfavourable step	€ 3,000 Equity 2025: € 3,000 Unchanged (€ 3,000) Unchanged
Total debts	€ 68,559 Total debts 2022: € 68,559 First fiscal year in the series	€ 22,250 Total debts 2023: € 22,250 ▼ 68% vs 2022 (€ 68,559) Favourable step	€ 126,582 Total debts 2024: € 126,582 ▲ € 104,332 vs 2023 (€ 22,250) Unfavourable step	€ 126,078 Total debts 2025: € 126,078 Unchanged (€ 126,582) Favourable step
Cash	€ 282,150 Cash 2022: € 282,150 First fiscal year in the series	€ 305,939 Cash 2023: € 305,939 ▲ 8% vs 2022 (€ 282,150) Favourable step	€ 63,313 Cash 2024: € 63,313 ▼ 79% vs 2023 (€ 305,939) Unfavourable step	€ 41,799 Cash 2025: € 41,799 ▼ 34% vs 2024 (€ 63,313) Unfavourable step	▼ 34%
Land & buildings	-	-	-	€ 11,609 Land & buildings 2025: € 11,609 First fiscal year in the series
Retained profit	€ 237,025 Retained profit 2022: € 237,025 First fiscal year in the series	€ 317,163 Retained profit 2023: € 317,163 ▲ 34% vs 2022 (€ 237,025) Favourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 317,163) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 416,347 Dividend 2024: € 416,347 Unchanged (€ 0) Unchanged	€ 108,557 Dividend 2025: € 108,557 ▼ 74% vs 2024 (€ 416,347) Unchanged	▼ 74%
Balance sheet total	€ 308,584 Balance sheet total 2022: € 308,584 First fiscal year in the series	€ 342,414 Balance sheet total 2023: € 342,414 ▲ 11% vs 2022 (€ 308,584) Unchanged	€ 129,582 Balance sheet total 2024: € 129,582 ▼ 62% vs 2023 (€ 342,414) Unchanged	€ 129,078 Balance sheet total 2025: € 129,078 Unchanged (€ 129,582) Unchanged

Key figures of DR. KAREL BUYSE ,HUISARTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. KAREL BUYSE ,HUISARTS?

What happened at DR. KAREL BUYSE ,HUISARTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 8, 2026 New annual accounts for financial year 2025: profit of € 108,557 (▲ 9% vs 2024). Source: NBB ↗
Apr 19, 2021 New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
2021 Karel Buyse became a director. NBB
Apr 19, 2021 Start of the company according to the CBE. KBO

In short

From € 87,050 profit in 2022 to € 108,557 profit in 2025.

Paid € 108,431 in corporate taxes since 2022.

Best year ever: 2025, with € 108,557 profit.

Paid out € 524,904 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. KAREL BUYSE ,HUISARTS? We notify you, reason included.

Follow DR. KAREL BUYSE ,HUISARTS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Karel Buyse

DR. KAREL BUYSE ,HUISARTS

Behind DR. KAREL BUYSE ,HUISARTS is Karel Buyse.

See the full network in the app

Directors

According to the 2025 annual accounts

Karel Buyse

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Donckerhoevestraat 7

9150 Beveren-Kruibeke-Zwijndrecht

2.316.357.228

Geeraard de Cremerstraat 124

9150 Beveren-Kruibeke-Zwijndrecht

Active since 19 April 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. Dries Buytaert, Huisarts

€ 198,114 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0766.894.569
VAT number: BE 0766.894.569
Registered office: Donckerhoevestraat 7, 9150 Beveren-Kruibeke-Zwijndrecht
Names & denominations: DR. KAREL BUYSE ,HUISARTS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 April 2021
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗